A detailed history of Times Square Capital Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Times Square Capital Management, LLC holds 697,265 shares of DXCM stock, worth $52.9 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
697,265
Previous 704,480 1.02%
Holding current value
$52.9 Million
Previous $79.9 Million 41.49%
% of portfolio
0.72%
Previous 1.27%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$64.0 - $116.06 $461,760 - $837,372
-7,215 Reduced 1.02%
697,265 $46.7 Million
Q2 2024

Aug 08, 2024

SELL
$110.31 - $140.45 $1.13 Million - $1.43 Million
-10,200 Reduced 1.43%
704,480 $79.9 Million
Q1 2024

May 07, 2024

SELL
$114.22 - $140.1 $6.16 Million - $7.55 Million
-53,910 Reduced 7.01%
714,680 $99.1 Million
Q4 2023

Feb 07, 2024

BUY
$75.49 - $124.16 $2.66 Million - $4.37 Million
35,210 Added 4.8%
768,590 $95.4 Million
Q3 2023

Nov 17, 2023

BUY
$86.06 - $137.93 $62.6 Million - $100 Million
726,980 Added 11359.06%
733,380 $68.4 Million
Q2 2023

Aug 09, 2023

SELL
$112.47 - $130.98 $22,494 - $26,195
-200 Reduced 3.03%
6,400 $822,000
Q1 2023

May 10, 2023

BUY
$104.0 - $122.92 $31,200 - $36,876
300 Added 4.76%
6,600 $767,000
Q4 2022

Feb 10, 2023

SELL
$84.98 - $122.67 $144,466 - $208,539
-1,700 Reduced 21.25%
6,300 $713,000
Q3 2022

Nov 09, 2022

BUY
$76.35 - $94.18 $610,800 - $753,440
8,000 New
8,000 $644,000
Q2 2019

Aug 02, 2019

SELL
$27.84 - $38.92 $6.73 Million - $9.41 Million
-241,800 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$28.07 - $38.18 $6.65 Million - $9.04 Million
-236,800 Reduced 49.48%
241,800 $28.8 Million
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $402,151 - $556,813
14,900 Added 3.21%
478,600 $57.3 Million
Q3 2018

Nov 14, 2018

BUY
$23.35 - $36.72 $10.8 Million - $17 Million
463,700 New
463,700 $0

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Times Square Capital Management, LLC Portfolio

Follow Times Square Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.